Lapi Francesco, Cecchi Enrica, Pedone Claudio, Attanasio Francesco, Banchelli Grazia, Vannacci Alfredo, Di Pirro Marina, Moschini Martina, Berni Valentina, Matucci Rosanna, Cini Elisabetta, Scalia Antonino, Tendi Enrico, Mugelli Alessandro
Tuscan Regional Centre of Pharmacovigilance, Department of Pharmacology, University of Florence, Viale G. Pieraccini no. 6, 50139 Florence, Italy.
Eur J Clin Pharmacol. 2008 Jul;64(7):723-37. doi: 10.1007/s00228-008-0477-7. Epub 2008 Apr 10.
More than 380,000 angiographic procedures are performed every year in Italian hospitals, with an increase rate of 8% per year. Although contrast media (CM) are considered relatively safe, adverse drug reactions (ADRs) remain an important issue.
The objective of this study was to quantify the incidence of immediate and delayed nonrenal ADRs to iodinated CM in an Italian cohort and to evaluate whether their different physicochemical properties are able to affect the incidence of immediate or delayed ADRs.
A prospective intensive monitoring study was conducted on a cohort of patients undergoing radiodiagnostic procedures with iodinated CM enrolled in two hospitals in Tuscany, Italy. To evaluate both immediate (within 1 h after CM administration) and delayed (>1 h to 1 week after CM administration) ADRs to CM, two questionnaires were administered. Adverse events (AEs) were analyzed to check the causality assessment between CM and ADR. If more than one symptom occurred in the same patient, they were treated as a single event.
One thousand five hundred and fourteen subjects who were exposed to iodinated CM completed the questionnaires. Mean age [standard deviation (SD)] was 65.4 (13.3) years, and 57.9% were male patients. A total of 178 [11.8%; 95% confidence interval (CI) 10.1-13.4] ADRs were reported. Thirty-four (2.2%; 1.5-3.1) and 144 (9.5%; 8.0-11.1) developed immediate and delayed ADRs, respectively. Both types of ADRs were experienced by six subjects (0.4%; 0.1-0.8). One hundred and seventy-six cases (98.8%; 96.0-99.8) were classified as possible and two (1.1%; 0.1-3.9) as probable ADRs. Monomeric low-osmolal (iopromide, iomeprol, iobitridol) and dimeric iso-osmolal (iodixanol) groups mainly reported delayed allergy-like ADRs of mild severity. Only one immediate reaction was severe. Multivariate analysis confirmed a higher risk of immediate reactions occurring for monomeric CM (OR 4.3; 95% CI 1.2-15.7), whereas the risk of delayed ADRs was significantly higher for the dimeric group (OR 1.8; 1.1-2.5).
Monomeric CM were more frequently involved in immediate ADRs, whereas dimeric CM were involved in delayed reactions. Although severe life-threatening ADRs to CM were confirmed to be rare, due to the large use of these drugs, they still retain clinical and epidemiological significance.
意大利医院每年进行超过38万例血管造影检查,且每年以8%的速度增长。尽管造影剂(CM)被认为相对安全,但药物不良反应(ADR)仍然是一个重要问题。
本研究的目的是量化意大利队列中碘造影剂引起的即刻和迟发性非肾性ADR的发生率,并评估其不同的理化性质是否会影响即刻或迟发性ADR的发生率。
对意大利托斯卡纳地区两家医院中接受碘造影剂放射诊断程序的患者队列进行了一项前瞻性强化监测研究。为了评估造影剂的即刻(造影剂给药后1小时内)和迟发性(造影剂给药后>1小时至1周)ADR,发放了两份问卷。对不良事件(AE)进行分析,以检查造影剂与ADR之间的因果关系评估。如果同一患者出现多种症状,则将其视为单一事件。
1514名接触碘造影剂的受试者完成了问卷。平均年龄[标准差(SD)]为65.4(13.3)岁,男性患者占57.9%。共报告了178例[11.8%;95%置信区间(CI)10.1-13.4]ADR。分别有34例(2.2%;1.5-3.1)和144例(9.5%;8.0-11.1)出现即刻和迟发性ADR。6名受试者(0.4%;0.1-0.8)同时经历了两种类型的ADR。176例(98.8%;96.0-99.8)被分类为可能的ADR,2例(1.1%;0.1-3.9)被分类为很可能的ADR。单体低渗(碘普罗胺、碘美普尔、碘比醇)和二聚体等渗(碘克沙醇)组主要报告轻度迟发性过敏样ADR。只有1例即刻反应严重。多变量分析证实,单体造影剂发生即刻反应的风险更高(比值比4.3;95%CI 1.2-15.7),而二聚体组迟发性ADR的风险显著更高(比值比1.8;1.1-2.5)。
单体造影剂更常与即刻ADR相关,而二聚体造影剂与迟发性反应相关。尽管造影剂引起的严重危及生命的ADR确实很少见,但由于这些药物的大量使用,它们仍然具有临床和流行病学意义。